Contact
searchSearch
HMP Global

Volume 18 - Issue 4 - April, 2006

Feature

Case Report
Buddy Wire Technique: A simple Technique for Treating Calcified Lesion during Percutaneous Coronary Intervention: A Case Report
08/01/2008
The use of a second 0.014 inch coronary guidewire, along with the one being used to advance balloons or stents inside the coronary arteries during percutaneous coronary intervention (PCI), sometimes helps to address complex lesions — a method...
The use of a second 0.014 inch coronary guidewire, along with the one being used to advance balloons or stents inside the coronary arteries during percutaneous coronary intervention (PCI), sometimes helps to address complex lesions — a method...
The use of a second 0.014 inch...
08/01/2008
Journal of Invasive Cardiology
Case Report
Filters to Prevent Distal Embolization during Coronary Artery Stenting: The Risk of Mousetrap
08/01/2008
Recently, a number of clinical studies demonstrated that distal embolization occurs routinely during percutaneous coronary interventions (PCI) — not only on saphenous vein grafts, but also on native coronary arteries.1–9 During primary PCI,...
Recently, a number of clinical studies demonstrated that distal embolization occurs routinely during percutaneous coronary interventions (PCI) — not only on saphenous vein grafts, but also on native coronary arteries.1–9 During primary PCI,...
Recently, a number of clinical...
08/01/2008
Journal of Invasive Cardiology
Case Report
Abciximab in ST-Elevation Acute Myocardial Infarction Occurring in a Heart Transplant Recipient and Treated with Stenting
08/01/2008
Accelerated allograft vasculopathy in cardiac transplant recipients occurs commonly five or more years after transplantation and limits patient survival.1,2 Unlike native atherosclerosis, this peculiar vasculopathy has a diffuse pattern of...
Accelerated allograft vasculopathy in cardiac transplant recipients occurs commonly five or more years after transplantation and limits patient survival.1,2 Unlike native atherosclerosis, this peculiar vasculopathy has a diffuse pattern of...
Accelerated allograft...
08/01/2008
Journal of Invasive Cardiology
Case Report
Stent Fracture and Collapse in a Saphenous Vein Graft Causing Occlusive Restenosis
08/01/2008
Percutaneous coronary intervention has revolutionized the management of coronary artery disease since its inception in 1977. Initial problems with acute vessel closure were largely solved with the advent of stenting.1 Recurrent stenosis...
Percutaneous coronary intervention has revolutionized the management of coronary artery disease since its inception in 1977. Initial problems with acute vessel closure were largely solved with the advent of stenting.1 Recurrent stenosis...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
Case Report
Early Aneurysm Formation after Drug-Eluting Stent Implantation: An Unusual Life-Threatening Complication
08/01/2008
Drug-eluting stents have ushered in a new era in interventional cardiology with the availability of sirolimus-eluting Cypher™ (Cordis Corp., Miami, Florida) and paclitaxel-eluting Taxus® (Boston Scientific Corp., Natick, Massachusetts) stents...
Drug-eluting stents have ushered in a new era in interventional cardiology with the availability of sirolimus-eluting Cypher™ (Cordis Corp., Miami, Florida) and paclitaxel-eluting Taxus® (Boston Scientific Corp., Natick, Massachusetts) stents...
Drug-eluting stents have ushered...
08/01/2008
Journal of Invasive Cardiology
Case Report
Coronary Perforation after Percutaneous Coronary Intervention Successfully Treated with Local Thrombin Injection
08/01/2008
Coronary perforation is a rare but potentially life-threatening complication of percutaneous coronary intervention (PCI). As an increasing number of complex PCI procedures are undertaken with aggressive anticoagulation and antiplatelet...
Coronary perforation is a rare but potentially life-threatening complication of percutaneous coronary intervention (PCI). As an increasing number of complex PCI procedures are undertaken with aggressive anticoagulation and antiplatelet...
Coronary perforation is a rare...
08/01/2008
Journal of Invasive Cardiology

Insights

Commentary
Prevention and Management of Radial Artery Spasm
08/01/2008
Radial artery spasm is frequently associated with transradial coronary access. Incidence varies around 10% and is caused by many factors. Spasm rarely leads to serious complications such as eversion atherectomy,1 but is commonly associated...
Radial artery spasm is frequently associated with transradial coronary access. Incidence varies around 10% and is caused by many factors. Spasm rarely leads to serious complications such as eversion atherectomy,1 but is commonly associated...
Radial artery spasm is...
08/01/2008
Journal of Invasive Cardiology
Combination Therapy with Aspirin, Clopidogrel and Warfarin Following Coronary Stenting is Associated with a Significant Risk of
08/01/2008
Dual antiplatelet therapy of aspirin and a thienopyridine has been established as the standard of care in patients undergoing coronary stent implantation.1–4 Those patients who require chronic anticoagulation for prosthetic cardiac valves,...
Dual antiplatelet therapy of aspirin and a thienopyridine has been established as the standard of care in patients undergoing coronary stent implantation.1–4 Those patients who require chronic anticoagulation for prosthetic cardiac valves,...
Dual antiplatelet therapy of...
08/01/2008
Journal of Invasive Cardiology
Morphology and Location of Restenosis Following Bare Metal Coronary Stenting
08/01/2008
Coronary stent implantation decreases restenosis rates when compared with percutaneous transluminal coronary angioplasty (PTCA),1,2 and the use of these endoluminal scaffolds has increased dramatically since their introduction.3 The most...
Coronary stent implantation decreases restenosis rates when compared with percutaneous transluminal coronary angioplasty (PTCA),1,2 and the use of these endoluminal scaffolds has increased dramatically since their introduction.3 The most...
Coronary stent implantation...
08/01/2008
Journal of Invasive Cardiology
A Multicenter, Randomized, Dose-Finding Study of Gamma Intracoronary Radiation Therapy to Inhibit Recurrent Restenosis after Ste
08/01/2008
Intracoronary radiation therapy (ICRT) for in-stent restenosis within bare metal stents substantially reduces the risk of recurrence.1–3 However, target vessel failure remains a significant clinical problem for some patients. A higher...
Intracoronary radiation therapy (ICRT) for in-stent restenosis within bare metal stents substantially reduces the risk of recurrence.1–3 However, target vessel failure remains a significant clinical problem for some patients. A higher...
Intracoronary radiation therapy...
08/01/2008
Journal of Invasive Cardiology

News

AHA Scientific Statement
New American Heart Association Scientific Statement on Pulmonary Embolism Management & Outcomes
03/21/2025
A new scientific statement from the American Heart Association, Disparities in Current Pulmonary Embolism Management and Outcomes, summarizes differences in diagnosis, treatment strategies and long-term outcomes related to PE.
A new scientific statement from the American Heart Association, Disparities in Current Pulmonary Embolism Management and Outcomes, summarizes differences in diagnosis, treatment strategies and long-term outcomes related to PE.
A new scientific statement from...
03/21/2025
Cath Lab Digest
Therapeutics
Alnylam Announces FDA Approval of Amvuttra (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hospitalizations and Urgent Heart Failure Visits in Adults with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM)
03/21/2025
The approval expands the indication for AMVUTTRA, which now becomes the first and only therapeutic approved by the FDA for the treatment of ATTR-CM and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
The approval expands the indication for AMVUTTRA, which now becomes the first and only therapeutic approved by the FDA for the treatment of ATTR-CM and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
The approval expands the...
03/21/2025
Cath Lab Digest
TAVR
Medtronic’s Evolut Trial Outcome Could Shake Up US TAVR Market, Says GlobalData
03/21/2025
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results...
03/21/2025
Vascular Disease Management
SCAI
JSCAI Special Issue Explores the Transformative Role of Artificial Intelligence in Interventional Cardiology
03/18/2025
"AI is now an integral part of our daily lives, whether we are prepared for it or not. In medicine, particularly in interventional cardiology, its impact is profound,” said guest editor Elazer R. Edelman, MD, PhD.
"AI is now an integral part of our daily lives, whether we are prepared for it or not. In medicine, particularly in interventional cardiology, its impact is profound,” said guest editor Elazer R. Edelman, MD, PhD.
"AI is now an integral part of...
03/18/2025
Cath Lab Digest
Acquisitions
Ostial Corporation Becomes Verge Medical Following Strategic Acquisition
03/17/2025
Ostial Corporation, focused on addressing the clinical challenges of aorto-ostial interventions, announced the acquisition of the Wavella™ technology from Crossfire Medical. The company also unveiled its new identity as Verge Medical.
Ostial Corporation, focused on addressing the clinical challenges of aorto-ostial interventions, announced the acquisition of the Wavella™ technology from Crossfire Medical. The company also unveiled its new identity as Verge Medical.
Ostial Corporation, focused on...
03/17/2025
Cath Lab Digest
AltiX AI.i ComboLab
AI
GE HealthCare Expands Invasive Cardiology Portfolio With AltiX AI.i for Cath Lab and EP Procedures 
03/17/2025
The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features...
The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features...
The AltiX AI.i editions are...
03/17/2025
Cath Lab Digest
Heart Formation
New Hope for Heart Disease: Unlocking How the Heart Forms Before Birth
03/17/2025
Dr. Mingfu Wu and his team's findings, published in Science, focus on long, thin, channels of membranes – called Tunneling Nanotube-Like Structures - that connect cells together.
Dr. Mingfu Wu and his team's findings, published in Science, focus on long, thin, channels of membranes – called Tunneling Nanotube-Like Structures - that connect cells together.
Dr. Mingfu Wu and his team's...
03/17/2025
Cath Lab Digest
Out-of-Hospital Cardiac Arrest
ESC: Resuscitation in Out-of-Hospital Cardiac Arrest – It’s How Quickly It Is Done, Rather Than Who Does It
03/17/2025
The fact that 80% of out-of-hospital cardiac arrests (OHCA) occur in residential settings highlights the crucial need for further public education and Basic Life Support (BLS) training to improve survival rates.
The fact that 80% of out-of-hospital cardiac arrests (OHCA) occur in residential settings highlights the crucial need for further public education and Basic Life Support (BLS) training to improve survival rates.
The fact that 80% of...
03/17/2025
Cath Lab Digest
Heart Failure
U.S. FDA Accepts Supplemental New Drug Application Under Priority Review for New Indication for KERENDIA® (finerenone) in Patients with Heart Failure with Left Ventricular Ejection Fraction of ≥40%
03/17/2025
KERENDIA® (finerenone) is the first non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA) to meet a primary cardiovascular (CV) endpoint in a Phase III study investigating patients with heart failure (HF) with mildly reduced...
KERENDIA® (finerenone) is the first non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA) to meet a primary cardiovascular (CV) endpoint in a Phase III study investigating patients with heart failure (HF) with mildly reduced...
KERENDIA® (finerenone) is the...
03/17/2025
Cath Lab Digest
CAD Diagnosis: AI
Caristo Diagnostics Receives U.S. FDA 510(k) Clearance of CaRi-Plaque Technology, an AI-assisted Image Analysis Application to Aid the Diagnosis of Coronary Artery Disease (CAD)
03/13/2025
CaRi-Plaque builds on Caristo’s breakthrough core CaRi-Heart® technology, which a landmark Lancet 2024 study proved can reveal hidden, high-risk markers of CAD progression — predicting heart attacks up to a decade before they strike.
CaRi-Plaque builds on Caristo’s breakthrough core CaRi-Heart® technology, which a landmark Lancet 2024 study proved can reveal hidden, high-risk markers of CAD progression — predicting heart attacks up to a decade before they strike.
CaRi-Plaque builds on Caristo’s...
03/13/2025
Cath Lab Digest

Endologix Announces 1000 Patients Treated With the DETOUR System
03/21/2025
Percutaneous Transmural Arterial Bypass (PTAB) with the DETOUR System offers a novel approach to treating complex PAD, enabling physicians to percutaneously bypass lesions in the superficial femoral artery by using stents routed through the...
Percutaneous Transmural Arterial Bypass (PTAB) with the DETOUR System offers a novel approach to treating complex PAD, enabling physicians to percutaneously bypass lesions in the superficial femoral artery by using stents routed through the...
Percutaneous Transmural Arterial...
03/21/2025
Cath Lab Digest
AHA Scientific Statement
New American Heart Association Scientific Statement on Pulmonary Embolism Management & Outcomes
03/21/2025
A new scientific statement from the American Heart Association, Disparities in Current Pulmonary Embolism Management and Outcomes, summarizes differences in diagnosis, treatment strategies and long-term outcomes related to PE.
A new scientific statement from the American Heart Association, Disparities in Current Pulmonary Embolism Management and Outcomes, summarizes differences in diagnosis, treatment strategies and long-term outcomes related to PE.
A new scientific statement from...
03/21/2025
Cath Lab Digest
Therapeutics
Alnylam Announces FDA Approval of Amvuttra (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hospitalizations and Urgent Heart Failure Visits in Adults with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM)
03/21/2025
The approval expands the indication for AMVUTTRA, which now becomes the first and only therapeutic approved by the FDA for the treatment of ATTR-CM and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
The approval expands the indication for AMVUTTRA, which now becomes the first and only therapeutic approved by the FDA for the treatment of ATTR-CM and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
The approval expands the...
03/21/2025
Cath Lab Digest
TAVR
Medtronic’s Evolut Trial Outcome Could Shake Up US TAVR Market, Says GlobalData
03/21/2025
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results...
03/21/2025
Vascular Disease Management
SCAI
JSCAI Special Issue Explores the Transformative Role of Artificial Intelligence in Interventional Cardiology
03/18/2025
"AI is now an integral part of our daily lives, whether we are prepared for it or not. In medicine, particularly in interventional cardiology, its impact is profound,” said guest editor Elazer R. Edelman, MD, PhD.
"AI is now an integral part of our daily lives, whether we are prepared for it or not. In medicine, particularly in interventional cardiology, its impact is profound,” said guest editor Elazer R. Edelman, MD, PhD.
"AI is now an integral part of...
03/18/2025
Cath Lab Digest
ES image
CRT Conference Coverage
Future Direction for RDN: From Hypertension to AFib and Beyond
03/18/2025
In this video from CRT 2025, JIC speaks with Dr Eric Secemsky of the Beth Israel Deaconness Medical Center about the future of renal denervation in atrial fibrillation treatment.
In this video from CRT 2025, JIC speaks with Dr Eric Secemsky of the Beth Israel Deaconness Medical Center about the future of renal denervation in atrial fibrillation treatment.
In this video from CRT 2025, JIC...
03/18/2025
Journal of Invasive Cardiology
Acquisitions
Ostial Corporation Becomes Verge Medical Following Strategic Acquisition
03/17/2025
Ostial Corporation, focused on addressing the clinical challenges of aorto-ostial interventions, announced the acquisition of the Wavella™ technology from Crossfire Medical. The company also unveiled its new identity as Verge Medical.
Ostial Corporation, focused on addressing the clinical challenges of aorto-ostial interventions, announced the acquisition of the Wavella™ technology from Crossfire Medical. The company also unveiled its new identity as Verge Medical.
Ostial Corporation, focused on...
03/17/2025
Cath Lab Digest
AltiX AI.i ComboLab
AI
GE HealthCare Expands Invasive Cardiology Portfolio With AltiX AI.i for Cath Lab and EP Procedures 
03/17/2025
The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features...
The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features...
The AltiX AI.i editions are...
03/17/2025
Cath Lab Digest
Heart Formation
New Hope for Heart Disease: Unlocking How the Heart Forms Before Birth
03/17/2025
Dr. Mingfu Wu and his team's findings, published in Science, focus on long, thin, channels of membranes – called Tunneling Nanotube-Like Structures - that connect cells together.
Dr. Mingfu Wu and his team's findings, published in Science, focus on long, thin, channels of membranes – called Tunneling Nanotube-Like Structures - that connect cells together.
Dr. Mingfu Wu and his team's...
03/17/2025
Cath Lab Digest
Out-of-Hospital Cardiac Arrest
ESC: Resuscitation in Out-of-Hospital Cardiac Arrest – It’s How Quickly It Is Done, Rather Than Who Does It
03/17/2025
The fact that 80% of out-of-hospital cardiac arrests (OHCA) occur in residential settings highlights the crucial need for further public education and Basic Life Support (BLS) training to improve survival rates.
The fact that 80% of out-of-hospital cardiac arrests (OHCA) occur in residential settings highlights the crucial need for further public education and Basic Life Support (BLS) training to improve survival rates.
The fact that 80% of...
03/17/2025
Cath Lab Digest

April 2006 Volume 18 Issue 4

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use